The user shared their experience transitioning from finasteride to dutasteride for hair loss treatment. They discussed the effectiveness and side effects of both medications.
A user shared progress pictures showing significant hair growth after taking oral finasteride and oral minoxidil for 30 days. Other users expressed disbelief at the rapid results, with some attributing changes to camera effects.
A user shared a positive 5-year experience with oral finasteride and minoxidil for hair loss, noting improvement and stability. Others in the conversation also reported positive results with these treatments.
Scube3, a potential hair loss treatment, is unlikely to be released because it was given to a startup company, Amplifica, which may go bankrupt and fail to bring the treatment to market. Amplifica is prioritizing other treatments over Scube3, which could lead to financial loss and the end of Scube3's development.
The conversation introduces a specialized chatbot for ChatGPT Plus users that provides advice on hair loss treatments, drawing from research and community insights. It mentions treatments like RU58841, the "big 4" (likely minoxidil, finasteride, ketoconazole, and tretinoin), dutasteride mesotherapy, topical melatonin, microneedling, and rapamycin.
Quercetin and houttuynia cordata extract may stimulate hair growth by enhancing cellular energy metabolism and increasing growth factor secretion. Quercetin has low oral bioavailability, and its natural tint might stain the scalp if used topically.
Hair loss treatments advertised on Instagram are likely ineffective and considered scams. Effective treatments like Minoxidil and Finasteride don't need advertising due to high demand.
The conversation discusses hair loss treatments, specifically Minoxidil, finasteride, and RU58841. It mentions a CEO becoming the first patient for HairClone.
A user discusses fighting hair loss without finasteride, using minoxidil, ketoconazole shampoo, saw palmetto, pumpkin seed oil, pygeum, stinging nettles, biotin, a boar bristle brush, and a derma roller. Replies suggest finasteride is necessary for effective hair loss prevention.
A 17-year-old female is worried about hair loss, noticing thinning and bald spots. She plans to try burdock oil and castor oil, and if needed, Jamaican castor oil.
Doctors in the UK are hesitant to prescribe finasteride for hair loss, leading many to seek it from online pharmacies. Users discuss side effects and alternative treatments like minoxidil, with some opting for online purchases due to ease and availability.
The user has been using 1.25mg Finasteride, 5mg Oral Minoxidil, Ketoconazole shampoo, and dermastamping for 1.5 months, noticing thicker hair and less scalp visibility, though changes are more noticeable in photos than in real life. They experienced no side effects from Finasteride but had initial chest discomfort with Oral Minoxidil, which resolved, and they plan to continue updating on their progress.
A 33-year-old man shares his one-year progress using 5% Minoxidil and 0.5% Tretinoin cream, along with derma stamping and specific shampoos, to combat hair thinning and promote hair growth. He avoids using finasteride or dutasteride, despite suggestions from others to try them for long-term maintenance.
Minoxidil is unlikely to cause skin aging at typical doses, and concerns about collagen inhibition are mostly unfounded. Users suggest using sunscreen and tretinoin for skin health, and some combine minoxidil with finasteride for hair maintenance.
The user started using 1mg oral finasteride a year ago and added oral minoxidil 3-4 months ago, experiencing no side effects except initial aching. They found oral minoxidil more effective for regrowth and easier than topical due to its toxicity to dogs.
Hair loss is linked to a higher rate of body dysmorphic disorder (BDD), OCD, and depression. Finasteride and dutasteride are not linked to increased suicidal risk, though some users report mental health side effects.
A user experienced hair retention but sexual side effects after using dutasteride for a year. Others shared similar experiences with finasteride and dutasteride, suggesting consulting a doctor for persistent issues.
The conversation discusses natural, chemical-free methods for scalp health and hair regrowth, such as using oils like rosemary, ginger, castor, and peppermint. It seeks personal experiences and effective routines for hair regrowth, especially after chemo or stress-related hair thinning.
Hair regrowth and gender transition using finasteride, estrogen, and spironolactone. Significant hair regrowth and personal transformation were achieved through hormone replacement therapy.
The conversation is about obtaining custom-compounded topical finasteride in Germany due to side effects from oral finasteride. The user seeks a lower concentration solution separate from minoxidil, and others suggest self-mixing or trying alternatives like dutasteride.
The user experienced significant hair regrowth after three months of using topical minoxidil 5% and 1mg oral finasteride, along with addressing vitamin D and iron deficiencies. Some users expressed skepticism about the rapid results, while others congratulated the user on their progress.
A new alcohol-free, propylene glycol-free topical finasteride foam is available for prescription in Canada and the USA, offering a cleaner alternative for hair loss treatment. The product also offers a combination of 0.1% finasteride with 5% minoxidil and aims to be affordable and less irritating for sensitive scalps.
Minoxidil sulfate is considered for those unresponsive to regular minoxidil, with some trying a 10% formulation from Folligenz. Concerns exist about the product's stability and transparency, but some users report positive initial results.
Pelage Pharmaceuticals raised $120M for their hair loss treatment, PP405, showing strong investor confidence despite limited data. There is skepticism about its efficacy and long-term effects compared to treatments like GT20029.
The user experienced improved libido and erections after reducing DHT levels with 0.5mg of dutasteride once a week, despite previous side effects from finasteride. They are also on testosterone replacement therapy and have not noticed major personality changes.
Pelage is developing a topical hair follicle stem cell therapy, PP405, for non-scarring alopecias like androgenetic alopecia, with Phase III trials planned and a potential market launch by 2027. The treatment may not require continuous use after initial regrowth.